
All roads lead to COPD… or not?
Our understanding of the pathogenesis of COPD has changed very significantly over the past few years.

Our understanding of the pathogenesis of COPD has changed very significantly over the past few years.

Most patients with chronic obstructive pulmonary disease (COPD) have at least one additional, clinically relevant chronic disease. Those with the most severe airflow obstruction will die from respiratory failure, but most patients with COPD die from non-respiratory disorders, particularly cardiovascular diseases and cancer.

COPD is the elephant in the room for many patients with CVDs.

Chronic Obstructive Pulmonary Disease (COPD) is the third cause of death worldwide. While tobacco smoking is a key risk factor, COPD also occurs in never-smokers (NS).

Los próximos 3, 4 y 5 de mayo tendrán lugar el VII Simposium Internacional de la EPOC y Tabaco y el XVII Simposium Internacional sobre prevención y tratamiento del tabaquismo.

Patients with COPD can have acute episodes of worsening symptoms, known generically as exacerbations, which are clinically relevant because they involve an acute deterioration of the patient’s health status, worsen the patient’s prognosis, and are the main cause of economic expenditure associated with COPD.